1.Lake, RJ, et al. Risk ranking for foodborne microbial hazards in New Zealand: burden of disease estimates. Risk Analysis (in press).
2.Majowicz, SE, et al. Estimating the under-reporting rate for infectious gastrointestinal illness in Ontario. Canadian Journal of Public Health 2005; 96: 178–181.
3.Wheeler, JG, et al. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. British Medical Journal 1999; 318: 1046–1050.
4.de Wit, MA, et al. A comparison of gastroenteritis in a general practice-based study and a community-based study. Epidemiology and Infection 2001; 127: 389–397.
5.van Pelt, W, et al. Laboratory surveillance of bacterial gastroenteric pathogens in The Netherlands, 1991–2001. Epidemiology and Infection 2003; 130: 431–441.
6.Hall, GV, et al. Frequency of infectious gastrointestinal illness in Australia, 2002: regional, seasonal and demographic variation. Epidemiology and Infection 2006; 134: 111–118.
8.Adlam, SB, et al. Acute gastrointestinal illness in New Zealand: community study. Epidemiology and Infection (in press).
10.Sargeant, JM, et al. The burden of acute gastrointestinal illness in Ontario, Canada, 2005–2006. Epidemiology and Infection 2008; 136: 451–460.
11.de Wit, MAS, et al. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. American Journal of Epidemiology 2001; 154: 666–674.
12.Amar, CF, et al. Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993–1996). European Journal of Clinical Microbiology and Infectious Diseases 2007; 26: 311–323.
13.Hall, G, et al. Estimating community incidence of Salmonella. Campylobacter, and shiga toxin-producing Escherichia coli infections, Australia. Emerging Infectious Diseases 2008; 14: 1601–1609.
14.Voetsch, A, et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clinical Infectious Diseases 2004; 38 (Suppl. 3): S127–134.